Procter & Gamble to Co-Promote Novartis’ Enablex®
Business Review Editor
Abstract
Procter & Gamble Pharmaceuticals (P&GP) and Novartis entered into co-promotion agreement for P&GP’s Enablex® (darifenacin).
Full Text: pdf
Add comment

This work is licensed under a Creative Commons Attribution 3.0 License.